Phase O/I Study of AMG 232 Concentrations in Brain Tissue in Patients with Recurrent Glioblastoma and of AMG 232 in Combination with Radiation in Patients with Newly Diagnosed Glioblastoma and Unmethylated MGMT Promoters

Grant

Date/time Interval

  • January 21, 2020 - April 30, 2021
  • Total Award Amount

  • 6000.00
  • Direct Costs

  • 4040.00
  • Sponsor Award Id

  • ABTC 1604
  • Contributor

  • hfathall   Investigator  
  • mlobbous   Investigator  
  • xhan   Investigator  
  • Louis Nabors M.D.   Principal Investigator